Digital Content

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. We’ll assume you’re ok with this, but you can opt out if you wish. See our 

Footer

Column Name Goes Here

Footer V2

2024 Event

Event Global

New HLTH Insights Programs

Become a Hosted Buyer

Become a Sponsor/Exhibitor

Apply for Media Pass

Promote Your Presence

2023 Event

Event Global Footer

Startup Opportunities

Hotel

2022 Event

LLC Global

2021 Event

LLC Menu Official

LLC Menu

The Evolution of Telehealth—featuring Roy Schoenberg of Amwell

S1 Ep8: The Evolution of Telehealth—featuring Roy Schoenberg of Amwell

President and CEO

The Beat: Revolutionizing Disease Advancement Through Science and Tec

The role of AI should be primarily focused on helping people and providing better outcomes in healthcare. In this episode, Mike Montello, Senior Vice President of R&amp;D and Digital and Technology at GSK, explains the role of AI in driving drug discovery through genetics and genomics. He highlights AI&#39;s impact on clinical trial acceleration and cost reduction, mentioning the importance of transformation and acceleration for every pharma company. Montello also discusses the rise of generative AI, which will automate lots of mundane tasks, improving efficiency and productivity. He shares the criteria a quality startup must meet to collaborate with GSK, such as aligning with their priorities, and puts more focus on what technology can do for people than the other way around. Finally, Mike expresses his admiration for leaders such as Simon Sinek and Brené Brown who can inspire and motivate his efforts. Tune in and learn about the transformative power of technology in advancing healthcare! About Mike Montello:Mike Montello serves as the Senior Vice President, R&amp;D Digital and Tech at GSK, a pharmaceutical company that ranks among the top ten globally and generates over $36 billion in revenue. Oncology, immunology, respiratory disorders, HIV, and infectious illnesses are its strong therapeutic domains. Mike is a sponsor of multiple aspects of GSK&#39;s overall digital transformation, including the company&#39;s transition to a product-centric structure, its strategic alliances with IT firms, and its digital training initiatives. Building diverse teams and encouraging inclusive leaders are two things that particularly inspire and excite him personally. He gets his energy from speeding innovation through culture. His other main concern is giving GSK&#39;s AI machine learning engineers the best quality data in the safest manner possible. Over his career, Mike has worked to improve healthcare via the use of digital, data, and analytics technologies. Mike held the position of CIO at Quintiles prior to the company&#39;s 2018 rebranding as IQVIA. He was in charge of the technological platforms that allowed clinical trials to take place in over 100 nations. Along with leading the product teams that developed the next generation of clinical development data and analytics capabilities, decentralized trial platforms, and supported multiple tech acquisitions, Mike also directed the company&#39;s R&amp;D technology strategy following the merger with IMS and Quintiles. In addition to spending several years in IT leadership positions at Shire Pharmaceuticals, Mike spent twelve years working as a management consultant at Accenture, where he developed his basic understanding of biopharmaceuticals and technology.  Mike has a mechanical engineering degree and graduated from London Business School with an executive MBA. Things You’ll Learn:<ul><li>Every pharmaceutical company needs transformation and acceleration.</li><li>GSK is using AI to identify patients who are most likely to respond favorably to medicines and vaccines by leveraging appropriate data.</li><li>In the pharma sector, there is a constant need to accelerate clinical trials, drug discovery, and the commercialization process.</li><li>Large language models and AI will help us a lot with mundane activities.</li><li>We have to balance the benefits of AI with making sure we&#39;re doing things extremely responsibly.</li><li>It&#39;s less about the technology and more about serving people with that technology.</li></ul>Resources:<ul><li>Connect with and follow Mike Montello on <a href="https://www.linkedin.com/in/michaelmontello/" target="_blank">LinkedIn</a>.</li><li>Follow GSK on <a href="https://www.linkedin.com/company/gsk/" target="_blank">LinkedIn</a> and visit their <a href="https://www.linkedin.com/company/gsk/" target="_blank">website</a>.</li></ul>

S1 E4: The Beat: Revolutionizing Disease Advancement Through Science and Tech

SVP, R&D Digital and Tech

Democratizing Therapy with Telemental Health—featuring Dr. Varun Choudhary

We have come to understand the importance of mental wellness in recent years, especially during the COVID-19 pandemic. Nevertheless, many of us don’t have access to traditional therapy, or we’re hesitant to visit a psychiatrist’s office. And a growing number of people are looking to online therapy as an alternative. But can you build strong relationship with a therapist virtually? What does quality mental health care look like in a digital landscape? Dr. Varun Choudhary is a Board-Certified Forensic Psychiatrist and Chief Medical Officer at <a href="https://www.talkspace.com/" target="_blank">Talkspace</a>, a leading virtual behavioral health company that offers convenient and affordable access to a fully credentialed network of highly qualified mental health providers.  Dr. Choudhary has 17 years of experience in behavioral health, providing care to patients in the public sector, correctional arena, private practice and community-based settings. He is a specialist in the realm of teletherapy, population health and collaborative care. On this episode of HLTH Matters, Dr. Choudhary joins host Dr. Guatam Gulati to explain the concept of asynchronous text-based therapy and explore the benefits of building a relationship with a therapist online. Dr. Choudhary discusses the root causes of the mental health crisis in our country, describing how rates of depression and anxiety skyrocketed during the pandemic and why telepsychiatry remains popular while other forms of telehealth are in decline. Listen in for Dr. Choudhary’s insight on the future of telemental health care and learn how online therapy like Talkspace is democratizing mental wellness around the world. Topics Covered<ul><li>The significant shift in the way we think about mental health over the last 10 years</li><li>How the mental health reimbursement system is informed by the regulatory environment</li><li>How Talkspace pioneered the concept of asynchronous text-based therapy</li><li>The benefits of building a relationship with a therapist online (and when it’s more appropriate to meet face-to-face)</li><li>The potential for Talkspace to eventually add brick-and-mortar facilities to its comprehensive care model</li><li>What responsibility platforms like Talkspace bear in reporting potential criminal activity</li><li>How rates of depression and anxiety skyrocketed during the COVID crisis</li><li>Why telepsychiatry use did not drop off after the pandemic like other telehealth services</li><li>Dr. Choudhary’s insight on the root causes of the mental health crisis in our country</li><li>How Dr. Choudhary’s WHY aligns with the Talkspace mission to democratize therapy</li><li>The meditation practice Dr. Choudhary uses to preserve his own mental wellness</li></ul> Connect with Dr. Varun Choudhary<a href="https://www.talkspace.com/" target="_blank">Talkspace</a><a href="https://www.linkedin.com/in/varun-choudhary-m-d-m-a-dfapa-6226a367/" target="_blank">Dr. Choudhary on LinkedIn</a> Connect with Dr. Guatam Gulati<a href="https://www.hlth.com/" target="_blank">HLTH</a><a href="https://twitter.com/drgautamgulati" target="_blank">Dr. Gulati on Twitter </a><a href="https://www.linkedin.com/in/gautamgulati" target="_blank">Dr. Gulati on LinkedIn </a> Resources <a href="https://www.liebertpub.com/doi/abs/10.1089/tmj.2016.0114?journalCode=tmj" target="_blank">‘A Study of Asynchronous Mobile-Enabled SMS Text Psychotherapy’ in Telemedicine and e-Health</a><a href="https://www.amazon.com/Healing-Path-Mental-Illness-Health/dp/0593298047" target="_blank">Healing: Our Path from Mental Illness to Mental Health by Thomas Insel, MD</a><a href="https://www.kff.org/report-section/kff-cnn-mental-health-in-america-survey-findings/" target="_blank">KFF/CNN Survey on Mental Health in America</a><a href="https://www.prms.com/media/2330/ryan-haight-act.pdf" target="_blank">Ryan Haight Act</a><a href="https://www.magellanhealth.com/" target="_blank">Magellan Health</a><a href="https://www.nimh.nih.gov/about/director/messages/2021/one-year-in-covid-19-and-mental-health" target="_blank">COVID-19 and Mental Health</a><a href="https://www.vivekmurthy.com/together-book" target="_blank">Together: The Healing Power of Human Connection in a Sometimes Lonely World by Vivek H. Murthy, MD</a>

S3 Ep4: Democratizing Therapy with Telemental Health—featuring Dr. Varun Choudhary

Chief Medical Officer

Building an Apple-Like Healthcare Experience—featuring Diogo Rau

There’s a lot of fear around applying artificial intelligence to the life sciences.  And while Diogo Rau concedes that there are risks associated with using AI, the biggest risk is that we won’t use it. Diogo Rau is EVP and Chief Information and Digital Officer of <a href="https://www.lilly.com/" target="_blank">Eli Lilly &amp; Company</a>, where he leads their information technology, cybersecurity, digital health, advanced analytics and data science functions.  Prior to joining Lilly, Diogo served as Head of Engineering for Apple Retail and Partner at McKinsey &amp; Company. On this episode of HLTH Matters, Diogo joins host Dr. Gautam Gulati to discuss the use of AI to facilitate clinical trials and drug discovery in a patient-first world. Diogo explains how he is bringing Apple’s focus on the end user to life sciences, sharing his vision of what an Apple-like healthcare experience looks like and how to create a culture of innovation at Lilly. Listen in for Diogo’s insight on using tech to inspire behavior change in patients and learn how we might leverage AI to generate new medicines, improve clinical trials and facilitate personalized medicine. Topics Covered<ul><li>How Diogo is bringing Apple’s focus on the end user to life sciences</li><li>Diogo’s take on what differentiates customers from patients</li><li>What inspired Diogo’s transition from Apple to his current role at Lilly</li><li>Leveraging artificial intelligence to facilitate personalized medicine</li><li>Why Lilly is prioritizing AI-designed and generated medicines</li><li>How to discern when we can innovate fast in the life sciences space</li><li>Building a culture of innovation in a large company like Lilly</li><li>How Diogo thinks about Lilly’s role in the healthcare ecosystem</li><li>Diogo’s vision of what an Apple-like healthcare experience looks like</li><li>Using technology to facilitate prevention through behavior change</li><li>Why Lilly is working on both insulin drugs and diabetes prevention</li><li>Diogo’s mission to impact the way medicine gets to patients </li></ul> Connect with Diogo Rau<ul><li><a href="https://www.lilly.com/" target="_blank">Eli Lilly &amp; Company</a></li><li>Diogo on <a href="https://www.linkedin.com/in/diogo-rau-811217/" target="_blank">LinkedIn</a></li></ul> Connect with Dr. Jessica Shepherd &amp; Dr. Gautam Gulati<ul><li><a href="https://www.hlth.com/" target="_blank">HLTH</a></li><li>Dr. Shepherd on <a href="https://twitter.com/JShepherd_MD" target="_blank">X</a></li><li>Dr. Shepherd on <a href="https://www.linkedin.com/in/jessica-shepherd-md-mba-5ba9ab66/" target="_blank">LinkedIn</a></li><li>Dr. Gulati on <a href="https://twitter.com/drgautamgulati" target="_blank">X</a></li><li>Dr. Gulati on <a href="https://www.linkedin.com/in/gautamgulati/" target="_blank">LinkedIn</a></li></ul> Resources<ul><li><a href="https://hbr.org/2020/01/the-essential-clayton-christensen-articles" target="_blank">Clay Christensen’s Model of Disruptive Innovation</a></li><li><a href="https://jamesclear.com/atomic-habits" target="_blank">Atomic Habits by James Clear</a></li><li><a href="https://waitbutwhy.com/" target="_blank">Wait But Why Blog</a></li></ul>

S4 E27: Building an Apple-Like Healthcare Experience—featuring Diogo Rau

Executive Vice President and Chief Information and Digital Officer

Podcast

S1 Ep8: The Evolution of Telehealth—featuring Roy Schoenberg of Amwell

FEATURING